- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03698734
Evening Primrose Oil Efficacy in Second Trimester Abortion
October 4, 2018 updated by: Radwa Rasheedy Ali, Ain Shams University
Effect of Adding Evening Primrose Oil to Misoprostol in Second Trimester Abortion
efficacy of evening primrose oil in shortening the duration of induction in 2nd trimesteric missed abortion
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
100
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Abbassya
-
Cairo, Abbassya, Egypt, 11566
- Recruiting
- AinShams university maternity hospital
-
Contact:
- Ahmed K Maklad, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 33 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Primiparous women
Exclusion Criteria:
- Previous uterine incision( Cs, myomectomy,)
- Contraindications to medical or surgical uterine evacuations (eg, hemodynamically unstable, coagulopathy)
- Evidence of intra-uterine infection
- Rupture of fetal membranes.
- Intrauterine device in place.
- Allergy to prostaglandins or EPO
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: placebo
|
primiparous women with missed abortion between(13 to 24 weeks) will receive 1 capsule of placebo in addition to misopristol
|
Active Comparator: Evening primrose oil
|
primiparous women with missed abortion between(13 to 24 weeks) will receive 1 capsule of EPO( 1000mg) in addition to misopristol
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
duration of medical induction of abortion
Time Frame: up to 1 week
|
time needed for complete expulsion of fetus and placenta
|
up to 1 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
November 1, 2018
Primary Completion (Anticipated)
November 1, 2019
Study Completion (Anticipated)
November 1, 2019
Study Registration Dates
First Submitted
October 4, 2018
First Submitted That Met QC Criteria
October 4, 2018
First Posted (Actual)
October 9, 2018
Study Record Updates
Last Update Posted (Actual)
October 9, 2018
Last Update Submitted That Met QC Criteria
October 4, 2018
Last Verified
October 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pregnancy Complications
- Abortion, Spontaneous
- Abortion, Missed
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Peripheral Nervous System Agents
- Analgesics
- Sensory System Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents
- Antirheumatic Agents
- Antimetabolites
- Dermatologic Agents
- Hypolipidemic Agents
- Lipid Regulating Agents
- Evening primrose oil
Other Study ID Numbers
- ASU obstetrics hosp
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Missed Abortion
-
Cairo UniversityNot yet recruiting
-
Cairo UniversityActive, not recruiting
-
Shereen Rady Abou El-fetouhUnknown
-
Cairo UniversityUnknown
-
Dr.Dalia Mohammed Al Sayed ZakiBenha UniversityUnknown
-
Cairo UniversityUnknown
-
Hawler Medical UniversityNEGATIVECompleted
-
Assiut UniversityCompleted
-
Gynuity Health ProjectsTerminatedPregnancy | Missed AbortionArgentina, Gabon, Mexico, Pakistan
-
Hawler Medical UniversityHAWLER Maternity HospitalCompleted
Clinical Trials on Evening primrose oil(EPO)
-
St. Luke's Hospital, PennsylvaniaUnknown
-
Mayo ClinicNew Health InternationalCompletedCyclical Breast PainUnited States
-
University of ManitobaManitoba Medical Service FoundationCompleted
-
Cairo UniversityCompleted
-
University of MichiganNational Heart, Lung, and Blood Institute (NHLBI)CompletedType 2 Diabetes Mellitus | ThrombosisUnited States
-
Max Zeller Soehne AGCompleted
-
Assiut UniversityCompleted
-
Medical College and Hospital KolkataCompletedBenign Breast Disease | Mastalgia | Fibroadenoma | Fibrocystic Disease of BreastIndia
-
Charite University, Berlin, GermanyUniversity of JenaCompletedRheumatoid Arthritis
-
FDA Office of Orphan Products DevelopmentUniversity of Massachusetts, WorcesterCompletedJuvenile Rheumatoid Arthritis